Header Logo

Jessica Chubak

Concepts (295)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasms
18
2022
438
5.670
Why?
Colorectal Neoplasms
39
2024
613
4.660
Why?
Early Detection of Cancer
32
2025
501
4.160
Why?
Colonoscopy
20
2024
251
2.580
Why?
Survivors
6
2018
149
2.510
Why?
Breast Neoplasms
22
2020
949
2.300
Why?
Neoplasm Recurrence, Local
11
2018
244
2.170
Why?
Mass Screening
20
2024
661
2.000
Why?
Humans
96
2025
17611
1.950
Why?
Aged
66
2025
6095
1.910
Why?
Middle Aged
63
2025
7911
1.610
Why?
Electronic Health Records
7
2023
681
1.560
Why?
Occult Blood
13
2024
153
1.560
Why?
Algorithms
5
2020
233
1.510
Why?
Female
73
2025
12608
1.500
Why?
Cancer Survivors
3
2022
83
1.460
Why?
Health Services Research
4
2016
231
1.350
Why?
Adaptation, Psychological
4
2018
77
1.310
Why?
Guideline Adherence
4
2025
155
1.170
Why?
Male
45
2024
10008
1.100
Why?
Animal Assisted Therapy
2
2017
5
1.100
Why?
Child, Hospitalized
2
2017
14
1.090
Why?
Aged, 80 and over
22
2024
1900
1.090
Why?
Washington
17
2020
374
1.050
Why?
Antidepressive Agents
3
2015
155
1.020
Why?
Adenoma
7
2024
93
0.980
Why?
Uterine Cervical Neoplasms
5
2025
119
0.940
Why?
Risk Factors
19
2023
3325
0.910
Why?
Practice Guidelines as Topic
7
2025
318
0.900
Why?
United States
19
2024
3956
0.880
Why?
Comparative Effectiveness Research
3
2013
66
0.850
Why?
Postmenopause
7
2009
241
0.840
Why?
Epidemiologic Methods
2
2012
81
0.810
Why?
Adult
25
2025
7598
0.800
Why?
Bias
4
2022
102
0.770
Why?
Diabetes Mellitus
2
2018
487
0.750
Why?
Colonic Neoplasms
2
2019
155
0.740
Why?
Neoplasms, Second Primary
4
2018
29
0.720
Why?
Quality of Life
4
2018
507
0.700
Why?
Delivery of Health Care, Integrated
8
2017
531
0.700
Why?
Return to Work
1
2019
2
0.680
Why?
Oropharyngeal Neoplasms
1
2019
6
0.680
Why?
Patient Acceptance of Health Care
4
2022
382
0.670
Why?
Follow-Up Studies
10
2020
1210
0.660
Why?
Surveys and Questionnaires
8
2019
1309
0.650
Why?
Adenocarcinoma
4
2022
172
0.650
Why?
Proportional Hazards Models
6
2019
709
0.650
Why?
Carcinoma, Squamous Cell
1
2019
55
0.640
Why?
Age Factors
5
2024
917
0.610
Why?
Papillomavirus Infections
3
2025
133
0.590
Why?
Liver Cirrhosis
1
2017
35
0.580
Why?
Sensitivity and Specificity
6
2022
304
0.580
Why?
Carcinoma, Hepatocellular
1
2017
26
0.580
Why?
Health Expenditures
1
2018
75
0.570
Why?
Time Factors
6
2019
1086
0.560
Why?
Liver Neoplasms
1
2017
40
0.560
Why?
Cohort Studies
14
2025
2570
0.540
Why?
Anticarcinogenic Agents
1
2016
13
0.540
Why?
Feces
2
2016
80
0.530
Why?
Reproducibility of Results
2
2015
381
0.530
Why?
Patient Satisfaction
1
2017
211
0.530
Why?
Employment
1
2016
42
0.530
Why?
Oncology Service, Hospital
1
2015
1
0.530
Why?
Bonding, Human-Pet
1
2015
2
0.530
Why?
Endometrial Neoplasms
2
2007
35
0.520
Why?
Colonic Polyps
3
2023
34
0.520
Why?
Research
2
2013
64
0.520
Why?
Paroxetine
1
2015
23
0.520
Why?
Aspirin
1
2016
63
0.520
Why?
Mammography
3
2015
169
0.510
Why?
Population Surveillance
1
2017
263
0.510
Why?
Primary Prevention
1
2016
73
0.510
Why?
Insurance Coverage
1
2016
106
0.500
Why?
Uterine Cervical Dysplasia
3
2025
8
0.500
Why?
Psychometrics
1
2015
121
0.490
Why?
Antidepressive Agents, Tricyclic
2
2013
9
0.480
Why?
Insurance, Health
1
2016
181
0.480
Why?
Retrospective Studies
13
2023
2447
0.480
Why?
Practice Patterns, Physicians'
1
2017
330
0.470
Why?
Carcinoma, Ductal, Breast
2
2012
53
0.470
Why?
Professional Role
1
2013
10
0.460
Why?
Epidemiologic Studies
1
2013
29
0.440
Why?
Delivery of Health Care
6
2022
415
0.440
Why?
Medical Oncology
1
2013
32
0.440
Why?
Depressive Disorder
1
2015
222
0.440
Why?
Cardiovascular Diseases
2
2016
598
0.430
Why?
Preventive Medicine
1
2013
24
0.430
Why?
Behavioral Sciences
1
2012
2
0.430
Why?
Clinical Trials as Topic
1
2013
130
0.420
Why?
Health Personnel
1
2013
124
0.410
Why?
Reminder Systems
5
2017
80
0.410
Why?
Health Status Indicators
1
2012
64
0.400
Why?
Heart Diseases
1
2012
77
0.390
Why?
Health Policy
1
2012
122
0.390
Why?
Logistic Models
6
2018
926
0.360
Why?
Serotonin Uptake Inhibitors
1
2011
71
0.360
Why?
Registries
6
2019
471
0.360
Why?
Databases, Factual
1
2011
309
0.350
Why?
Animals
3
2017
259
0.350
Why?
Postal Service
5
2019
72
0.340
Why?
Drug Prescriptions
1
2011
151
0.340
Why?
Exercise
4
2007
489
0.330
Why?
Histamine H2 Antagonists
1
2009
13
0.330
Why?
Proton Pump Inhibitors
1
2009
24
0.330
Why?
Disease Progression
3
2016
264
0.330
Why?
Young Adult
10
2025
2427
0.330
Why?
Case-Control Studies
8
2023
1115
0.320
Why?
Patient Compliance
4
2017
298
0.320
Why?
Breast
1
2009
84
0.310
Why?
Health Care Costs
1
2010
228
0.310
Why?
Estrogens
2
2007
61
0.300
Why?
Research Design
5
2013
374
0.300
Why?
Predictive Value of Tests
3
2013
351
0.290
Why?
Progestins
1
2007
25
0.290
Why?
Estrogen Replacement Therapy
1
2007
99
0.280
Why?
Colposcopy
2
2023
4
0.280
Why?
Dogs
2
2017
17
0.280
Why?
Lung Neoplasms
3
2022
255
0.280
Why?
Thinness
1
2006
30
0.270
Why?
Odds Ratio
6
2019
671
0.260
Why?
Bone Density
1
2006
92
0.260
Why?
Hospitals, Pediatric
2
2017
79
0.260
Why?
Neoplasm Staging
7
2017
325
0.250
Why?
Cost-Benefit Analysis
2
2024
250
0.250
Why?
Antineoplastic Agents, Hormonal
2
2018
63
0.250
Why?
Adolescent
6
2019
3651
0.250
Why?
Patient Navigation
2
2015
14
0.240
Why?
SEER Program
5
2020
91
0.240
Why?
Anxiety
2
2018
150
0.240
Why?
Follicle Stimulating Hormone
1
2004
2
0.240
Why?
Estradiol
1
2004
23
0.240
Why?
Sex Hormone-Binding Globulin
1
2004
22
0.240
Why?
Risk Assessment
5
2019
1097
0.240
Why?
Patient-Centered Care
2
2016
197
0.220
Why?
Vaginal Smears
4
2025
48
0.220
Why?
Biomarkers, Tumor
1
2004
142
0.220
Why?
Survival Rate
2
2013
260
0.210
Why?
Primary Health Care
3
2022
766
0.200
Why?
Reproductive History
2
2017
17
0.200
Why?
Cross-Sectional Studies
4
2024
1322
0.200
Why?
Tamoxifen
2
2018
56
0.180
Why?
Intestinal Polyps
1
2020
7
0.180
Why?
Patient Selection
2
2012
190
0.170
Why?
Prostatic Neoplasms
1
2022
262
0.170
Why?
Interviews as Topic
2
2013
305
0.170
Why?
Symptom Assessment
1
2019
6
0.170
Why?
Child
2
2017
2474
0.170
Why?
Linear Models
3
2011
231
0.170
Why?
Papillomaviridae
3
2025
52
0.170
Why?
Socioeconomic Factors
3
2019
630
0.160
Why?
Cytochrome P-450 CYP2D6
1
2018
1
0.160
Why?
Educational Status
1
2019
200
0.160
Why?
Motivation
1
2019
130
0.160
Why?
Evidence-Based Medicine
1
2019
185
0.150
Why?
Diabetes Complications
1
2018
114
0.150
Why?
Healthcare Disparities
2
2019
201
0.150
Why?
Pediatric Nursing
1
2017
3
0.150
Why?
Incidence
2
2016
1255
0.150
Why?
Ultrasonography
1
2017
35
0.150
Why?
Nurses
2
2015
36
0.140
Why?
Contraceptives, Oral
1
2017
26
0.140
Why?
Comorbidity
2
2016
594
0.140
Why?
National Cancer Institute (U.S.)
1
2016
16
0.140
Why?
Analgesics, Opioid
1
2019
243
0.140
Why?
Pilot Projects
1
2017
218
0.140
Why?
Specimen Handling
1
2016
20
0.130
Why?
Overweight
3
2007
269
0.130
Why?
Antihypertensive Agents
1
2017
161
0.130
Why?
Risk
2
2015
516
0.130
Why?
Medical Records
1
2015
100
0.130
Why?
Health Surveys
1
2016
260
0.120
Why?
Inpatients
1
2015
81
0.120
Why?
Hypoglycemic Agents
1
2017
268
0.120
Why?
Outpatients
1
2015
107
0.120
Why?
Prognosis
3
2015
606
0.120
Why?
Self Efficacy
1
2014
68
0.120
Why?
Cardiovascular Agents
1
2014
24
0.110
Why?
Patient Advocacy
1
2013
13
0.110
Why?
Reagent Kits, Diagnostic
1
2013
10
0.110
Why?
Depressive Disorder, Major
1
2015
124
0.110
Why?
Observer Variation
1
2013
37
0.110
Why?
Utilization Review
1
2013
53
0.110
Why?
Selection Bias
1
2013
19
0.110
Why?
Observation
1
2013
23
0.110
Why?
Patient Care Planning
1
2013
52
0.110
Why?
Health Promotion
1
2016
280
0.110
Why?
Confidence Intervals
3
2013
237
0.110
Why?
Societies, Medical
1
2013
74
0.110
Why?
Confounding Factors (Epidemiology)
1
2013
86
0.110
Why?
Lymphoma, Non-Hodgkin
1
2013
24
0.110
Why?
Counseling
1
2015
189
0.110
Why?
Continuity of Patient Care
2
2011
105
0.110
Why?
Patient Preference
1
2013
48
0.110
Why?
Effect Modifier, Epidemiologic
1
2012
9
0.110
Why?
Recurrence
1
2013
186
0.110
Why?
Survival Analysis
1
2013
215
0.110
Why?
Hypertension
1
2017
500
0.100
Why?
Translational Medical Research
1
2012
35
0.100
Why?
Ovariectomy
1
2012
9
0.100
Why?
Outcome and Process Assessment (Health Care)
1
2012
102
0.100
Why?
Genetic Counseling
1
2012
26
0.100
Why?
Clinical Coding
1
2011
11
0.100
Why?
Drug Administration Schedule
2
2012
98
0.100
Why?
Program Evaluation
1
2012
223
0.100
Why?
Ovarian Neoplasms
1
2012
49
0.100
Why?
Anti-Bacterial Agents
1
2013
140
0.100
Why?
Specialization
1
2011
24
0.100
Why?
Randomized Controlled Trials as Topic
1
2012
322
0.090
Why?
Treatment Outcome
4
2015
1259
0.090
Why?
False Positive Reactions
1
2010
26
0.090
Why?
Longitudinal Studies
3
2020
710
0.090
Why?
Depression
1
2015
502
0.090
Why?
Diabetes Mellitus, Type 2
1
2017
748
0.090
Why?
Anti-Ulcer Agents
1
2009
5
0.080
Why?
Medication Adherence
1
2012
244
0.080
Why?
Ambulatory Care
1
2011
244
0.080
Why?
Phenotype
2
2020
149
0.080
Why?
Antineoplastic Agents
1
2009
59
0.080
Why?
Telephone
3
2017
161
0.080
Why?
Health Behavior
2
2012
359
0.080
Why?
Prospective Studies
1
2012
1267
0.080
Why?
Referral and Consultation
1
2009
167
0.080
Why?
Carcinoma, Lobular
1
2007
10
0.080
Why?
Sigmoidoscopy
3
2013
65
0.070
Why?
Pregnancy
2
2023
1494
0.070
Why?
Prolactin
1
2007
4
0.070
Why?
Medicare
2
2017
202
0.070
Why?
Multivariate Analysis
1
2007
568
0.060
Why?
Outcome Assessment (Health Care)
2
2017
228
0.060
Why?
Texas
1
2025
35
0.060
Why?
Quality-Adjusted Life Years
1
2024
38
0.060
Why?
Menstrual Cycle
1
2004
5
0.060
Why?
Androgens
1
2004
12
0.060
Why?
Testosterone
1
2004
22
0.060
Why?
Probability
1
2004
79
0.060
Why?
Adipose Tissue
1
2004
58
0.060
Why?
Parity
1
2004
74
0.060
Why?
Aromatase
1
2004
7
0.060
Why?
Steroid 17-alpha-Hydroxylase
1
2004
5
0.060
Why?
Aryl Hydrocarbon Hydroxylases
1
2004
6
0.060
Why?
Gonadal Steroid Hormones
1
2004
26
0.060
Why?
Age Distribution
1
2004
246
0.060
Why?
Polymorphism, Genetic
1
2004
62
0.060
Why?
Office Visits
2
2016
80
0.060
Why?
Obesity
2
2007
837
0.050
Why?
Papanicolaou Test
1
2022
37
0.050
Why?
Prostate-Specific Antigen
1
2022
75
0.050
Why?
California
2
2019
2284
0.050
Why?
Self Report
2
2013
251
0.050
Why?
Body Mass Index
4
2007
958
0.050
Why?
Proto-Oncogene Proteins B-raf
1
2020
15
0.040
Why?
Data Warehousing
1
2020
3
0.040
Why?
DNA Methylation
1
2020
41
0.040
Why?
Pandemics
1
2022
287
0.040
Why?
Weight Loss
1
2022
303
0.040
Why?
Medical History Taking
1
2019
35
0.040
Why?
Mutation
1
2020
128
0.040
Why?
Financial Support
1
2019
5
0.040
Why?
Biopsy
1
2019
74
0.040
Why?
Demography
1
2019
101
0.040
Why?
Age of Onset
1
2019
79
0.040
Why?
Cytochrome P-450 CYP2D6 Inhibitors
1
2018
2
0.040
Why?
Disease-Free Survival
1
2018
57
0.040
Why?
Attitude to Health
1
2019
164
0.040
Why?
Sulfonylurea Compounds
1
2017
24
0.040
Why?
Metformin
1
2017
57
0.040
Why?
Insulin
1
2017
205
0.030
Why?
Aftercare
1
2016
49
0.030
Why?
Idaho
1
2013
24
0.030
Why?
Sex Factors
1
2015
643
0.030
Why?
Costs and Cost Analysis
1
2013
80
0.030
Why?
Aromatase Inhibitors
1
2012
32
0.030
Why?
Treatment Refusal
1
2012
33
0.030
Why?
Residence Characteristics
1
2014
248
0.020
Why?
Regression Analysis
1
2012
297
0.020
Why?
Analysis of Variance
1
2011
159
0.020
Why?
Nursing Care
1
2010
4
0.020
Why?
Nursing Staff, Hospital
1
2010
11
0.020
Why?
Sample Size
1
2010
29
0.020
Why?
Quality Control
1
2010
45
0.020
Why?
Allied Health Personnel
1
2010
11
0.020
Why?
Genetic Predisposition to Disease
1
2012
368
0.020
Why?
Continental Population Groups
1
2012
302
0.020
Why?
Data Collection
1
2010
256
0.020
Why?
Chronic Disease
1
2011
428
0.020
Why?
Long-Term Care
1
2007
22
0.020
Why?
Feeding Behavior
1
2007
166
0.020
Why?
Radioimmunoassay
1
2004
4
0.010
Why?
Catechol O-Methyltransferase
1
2004
1
0.010
Why?
Cytochrome P-450 CYP1B1
1
2004
2
0.010
Why?
Health Knowledge, Attitudes, Practice
1
2007
375
0.010
Why?
Alleles
1
2004
84
0.010
Why?
Genotype
1
2004
227
0.010
Why?
Body Weight
1
2004
219
0.010
Why?
Tomography, X-Ray Computed
1
2004
205
0.010
Why?
Concepts (295)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
-->

© 2025 Kaiser Permanente